You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 163 No. 8, April 28, 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (14)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Thrombolysis
 •Venous Thromboembolism
 •Cardiovascular System
 •Surgery
 •Blood/ Coagulation
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Perioperative Management of Warfarin Therapy

Arch Intern Med. 2003;163:881-883.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

IF THERE is one thing that can be said with certainty about the perioperative management of oral anticoagulation as reviewed by Dunn and Turpie1 in this issue of the ARCHIVES, it is the authors' statement that "It is not possible to draw firm conclusions on the relative efficacy and safety of different management strategies using the available literature owing to variations in patient populations, procedures, anticoagulation regimens, definitions of events, and durations of follow-up." However, this is a management dilemma that is too important to say there is no answer. We must look at the available evidence, regardless of its quality, along with the extensive clinical experience with a drug that has been in use for over 60 years and try to arrive at recommendations as Dunn and Turpie have attempted to do in their timely review of this topic.

Unlike most medications, oral anticoagulants require frequent dose adjustments to . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Perioperative Management of Patients Receiving Oral Anticoagulants: A Systematic Review
Andrew S. Dunn and Alexander G. G. Turpie
Arch Intern Med. 2003;163(8):901-908.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Perioperative Management of Antithrombotic Therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Douketis et al.
Chest 2008;133:299S-339S.
ABSTRACT | FULL TEXT  

Enoxaparin as bridging anticoagulant treatment in cardiac surgery
Rivas-Gandara et al.
Heart 2008;94:205-210.
ABSTRACT | FULL TEXT  

"Bridging On the River Kwai": The Perioperative Management of Anticoagulation Therapy
Eckman
Med Decis Making 2005;25:370-373.
 

Single-Arm Study of Bridging Therapy With Low-Molecular-Weight Heparin for Patients at Risk of Arterial Embolism Who Require Temporary Interruption of Warfarin
Kovacs et al.
Circulation 2004;110:1658-1663.
ABSTRACT | FULL TEXT  

Thrombotic Disorders: Diagnosis and Treatment
Schafer et al.
ASH Education Book 2003;2003:520-539.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.